Published in J Interferon Res on August 01, 1987
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol (1990) 3.44
cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol (1989) 3.20
Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J (1990) 2.75
Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J (1992) 1.63
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol (1999) 1.62
Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol (1995) 1.56
Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J Virol (1998) 1.53
Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins. EMBO J (1988) 1.32
Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J Virol (1992) 1.28
Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, double-stranded RNA, certain cytokines, and viruses. J Virol (1989) 1.24
Spontaneous and differentiation-dependent regulation of measles virus gene expression in human glial cells. J Virol (1993) 1.02
Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem (2009) 0.97
Parental influenza virion nucleocapsids are efficiently transported into the nuclei of murine cells expressing the nuclear interferon-induced Mx protein. J Virol (1990) 0.96
Quantitative proteome profiling of lymph node-positive vs. -negative colorectal carcinomas pinpoints MX1 as a marker for lymph node metastasis. Int J Cancer (2014) 0.86
Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma. BMC Cancer (2016) 0.75
Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8. J Clin Microbiol (1987) 3.17
Predominance of capsular polysaccharide type 5 among oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1987) 2.01
Molecular characterization of the hdm2-p53 interaction. J Mol Biol (1997) 1.64
Inducibility of human beta-interferon gene in mouse L-cell clones. Nature (1982) 1.43
Identification of novel mdm2 binding peptides by phage display. Oncogene (1996) 1.37
MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis (1994) 1.29
The human intracellular Mx-homologous protein is specifically induced by type I interferons. Eur J Immunol (1990) 1.18
Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid. J Interferon Res (1989) 1.12
9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections. Antimicrob Agents Chemother (1989) 1.11
A method of preparing Escherichia coli 16 S RNA possessing previously unobserved 30 S ribosomal protein binding sites. J Mol Biol (1976) 1.11
Monoclonal antibody against human IFN-gamma. Nature (1982) 1.00
The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. AIDS (1990) 0.94
Monoclonal antibodies against human fibroblast interferon. Nature (1981) 0.92
Enhancement of host resistance against virus infections by MTP-PE, a synthetic lipophilic muramyl peptide--I. Increased survival in mice and guinea pigs after single drug administration prior to infection, and the effect of MTP-PE on interferon levels in sera and lungs. Int J Immunopharmacol (1986) 0.91
Significant changes in 16 S RNA conformation accompanying assembly of the 30 S ribosome in vitro. J Mol Biol (1977) 0.89
Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C. Hepatology (1994) 0.86
Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections. J Interferon Res (1989) 0.86
The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses. Experientia (1989) 0.85
The effect of recombinant human interferon alpha B/D compared to interferon alpha 2b on SIV infection in rhesus macaques. Antiviral Res (1996) 0.85
Cross-species antiviral activity of a recombinant human alpha-interferon hybrid. Ann N Y Acad Sci (1992) 0.82
Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemia. Blood (1991) 0.82
IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression. J Interferon Cytokine Res (1999) 0.81
Evidence for cross-linking of polyribonucleotides with 4'-aminomethyl-4,5',8-trimethylpsoralen hydrochloride. Biochemistry (1979) 0.80
Monoclonal antibodies to the multienzyme enniatin synthetase. Production and use in structural studies. Biol Chem Hoppe Seyler (1987) 0.80
An interferon-induced mouse protein involved in the mechanism of resistance to influenza viruses. Its purification to homogeneity and characterization by polyclonal antibodies. J Biol Chem (1985) 0.80
Transformation-related cellular protein p53: increased level in untransformed rat cells following treatment with the tumorpromoter, tetradecanoylphorbol-acetate. Z Naturforsch C (1986) 0.80
Evidence that 16S RNA from E. coli can assume two different biologically active conformations. Nucleic Acids Res (1976) 0.78
Correlation of the antiproliferative effect and the Mx-homologous protein induction by IFN in patients with malignant melanoma. J Invest Dermatol (1990) 0.76
Enhanced antiproliferative action of interferon targeted by bispecific monoclonal antibodies. J Interferon Res (1988) 0.76
Antiviral and antiproliferative effects of interferons delivered via monoclonal antibodies. J Interferon Res (1984) 0.75
Antagonism of interferon induction in spleen and adherent peritoneal cells of mice by the lipophilic antiviral muramyl peptide MTP-PE. J Interferon Res (1986) 0.75
Further evidence that the ribosomal 30S proteins S3, S5, S9, S11, S12, and S18 possess specific 16S RNA binding sites. Mol Gen Genet (1977) 0.75
Biological activities of human recombinant interferon alpha/beta targeted by anti-Epstein-Barr virus monoclonal antibodies. FEBS Lett (1985) 0.75
Links between effects of butyrate on histone hyperacetylation and regulation of interferon synthesis in Namalva and FS-4 cell lines. J Interferon Res (1982) 0.75
Monoclonal antibodies against human fibroblast interferon. Eur J Biochem (1981) 0.75
RNA of the small subunit of the Escherichia coli ribosome with additional protein binding sites. Characterization of the structure by electron microscopy. FEBS Lett (1977) 0.75
Early viral proteins as autoantigens. Evidence from JC virus large T antigen. Ann N Y Acad Sci (1988) 0.75
Demonstration of HIFN-beta in the liver of patients undergoing HIFN-beta treatment. FEBS Lett (1981) 0.75